Entrada Therapeutics Inc.

11.30
-0.64 (-5.36%)
At close: Mar 03, 2025, 3:59 PM
11.33
0.27%
After-hours: Mar 03, 2025, 04:00 PM EST

Entrada Therapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
PE Ratio 9.83 -74.6 -4.84 -10.68 -28.37 -160.98
PEG Ratio -0.01 0.80 -0.07 -0.12 -0.06 n/a
PS Ratio 3.06 3.87 n/a n/a n/a n/a
PB Ratio 1.50 2.06 1.99 1.79 -18.04 -48.23
P/FCF Ratio -14.43 3.72 -4.38 -9.64 -26.83 -65.47
P/OCF Ratio -15.52 3.57 -4.51 -10.51 -29.27 -69.29
OCF/S Ratio -0.2 1.08 n/a n/a n/a n/a
Debt / Equity Ratio 0.14 0.28 0.12 n/a n/a n/a
Quick Ratio 11.15 2.33 9.55 44.46 11.89 9.08
Current Ratio 11.15 2.33 9.55 44.46 11.89 9.08
Asset Turnover 0.40 0.27 n/a n/a n/a n/a
Interest Coverage n/a n/a -36.95 n/a n/a n/a
Return on Equity (ROE) 0.15 -0.03 -0.41 -0.17 0.64 0.30
Return on Assets (ROA) 0.12 -0.01 -0.35 -0.16 -0.61 -0.25
Return on Capital (ROIC) 0.10 -0.01 -0.42 -0.17 -0.66 -0.72
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% 22.58% n/a n/a n/a n/a
Net Profit Margin 31.13% -5.18% n/a n/a n/a n/a
Pretax Profit Margin 31.54% 9.34% n/a n/a n/a n/a
Operating Profit Margin 22.30% -2.45% n/a n/a n/a n/a
FCF Margin -21.21% 104.01% n/a n/a n/a n/a
EBITDA Margin 22.30% -0.25% n/a n/a n/a n/a